Variant report

Variant	nsv975118
Chromosome Location	chr11:66862674-66874347
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:15)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:66871455..66873562-chr11:66884732..66886796,2	MCF-7	breast:
2	chr11:66864656..66866300-chr11:67006191..67007792,2	MCF-7	breast:
3	chr11:66861259..66863217-chr11:66865259..66868293,3	K562	blood:
4	chr11:66864238..66866456-chr11:66880720..66884624,3	MCF-7	breast:
5	chr11:66868215..66869893-chr11:66872876..66875422,2	K562	blood:
6	chr11:66873611..66875559-chr11:66884875..66887591,2	K562	blood:
7	chr11:66868215..66869893-chr11:66872876..66875422,2	K562	blood:
8	chr11:66866214..66867775-chr11:66886323..66888277,2	MCF-7	breast:
9	chr11:66873657..66876002-chr11:66881014..66882848,3	MCF-7	breast:
10	chr11:66868018..66871206-chr11:66883775..66886927,3	MCF-7	breast:
11	chr11:66862144..66862980-chr11:66935669..66936419,3	MCF-7	breast:
12	chr11:66873988..66875768-chr11:66877376..66880066,2	MCF-7	breast:
13	chr11:66861242..66864101-chr11:66886609..66888466,2	MCF-7	breast:
14	chr11:66861259..66863217-chr11:66865259..66868293,3	K562	blood:
15	chr11:66872090..66874276-chr11:66882740..66884363,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KDM2A-3	chr11:66870104-66870574	NONHSAT022375
2	lnc-KDM2A-2	chr11:66873885-66874221	NONHSAT022376
3	lnc-RHOD-2	chr11:66862403-66863401	NONHSAT022374

No data

Variant related genes	Relation type
ENSG00000173120	chromatin interactions

Extended variants
information (count: 446 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:446 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs139705410	chr11:66862686-66862687	Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
2	rs145294675	chr11:66862692-66862693	Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs559882442	chr11:66862715-66862716	Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs556063169	chr11:66862728-66862729	Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs545131715	chr11:66862770-66862771	Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs375493338	chr11:66862859-66862860	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs370225901	chr11:66862860-66862861	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs552006897	chr11:66862887-66862888	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs564049343	chr11:66862906-66862907	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs531541166	chr11:66862913-66862914	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs147628947	chr11:66862917-66862918	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs374476820	chr11:66862923-66862924	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs78199144	chr11:66862934-66862935	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs535560731	chr11:66862944-66862945	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
15	rs12287649	chr11:66862959-66862960	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs7941655	chr11:66863010-66863011	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs540040372	chr11:66863035-66863036	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs553217245	chr11:66863039-66863040	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs558448598	chr11:66863071-66863072	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs557077106	chr11:66863103-66863104	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs576796509	chr11:66863135-66863136	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs573188139	chr11:66863140-66863141	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
23	rs192298794	chr11:66863200-66863201	Enhancers Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
24	rs555872032	chr11:66863251-66863252	Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs78135535	chr11:66863301-66863302	Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs547587335	chr11:66863324-66863325	Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs541534437	chr11:66863329-66863330	Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs201590965	chr11:66863368-66863369	Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs545993076	chr11:66863403-66863404	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs184363306	chr11:66863453-66863454	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs556174670	chr11:66863467-66863468	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs12274690	chr11:66863468-66863469	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs374519706	chr11:66863472-66863473	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs545586242	chr11:66863473-66863474	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs373120304	chr11:66863476-66863477	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs563987900	chr11:66863489-66863490	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs559106418	chr11:66863495-66863496	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs187498003	chr11:66863518-66863519	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs543733468	chr11:66863536-66863537	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs561900419	chr11:66863556-66863557	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs529309973	chr11:66863657-66863658	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs575789826	chr11:66863678-66863679	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs566185227	chr11:66863686-66863687	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs557671965	chr11:66863743-66863744	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs533503926	chr11:66863751-66863752	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs551998948	chr11:66863752-66863753	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs142283066	chr11:66863774-66863775	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs150078007	chr11:66863801-66863802	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs556050621	chr11:66863809-66863810	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs567919393	chr11:66863848-66863849	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	16417655	CNVD
Myelofibrosis	22110671	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	19153074	CNVD
Schizophrenia	21346763	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:169 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:66850800-66866000	Weak transcription	Right Atrium	heart
2	chr11:66861200-66866200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr11:66862200-66863000	Enhancers	A549	lung
4	chr11:66862400-66862800	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr11:66862400-66862800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
6	chr11:66862400-66862800	Enhancers	Hela-S3	cervix
7	chr11:66862400-66863000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr11:66862400-66863000	Enhancers	Liver	Liver
9	chr11:66862400-66863000	Enhancers	K562	blood
10	chr11:66862400-66863200	Enhancers	H1 Cell Line	embryonic stem cell
11	chr11:66862600-66862800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr11:66862600-66862800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr11:66862600-66862800	Flanking Active TSS	HepG2	liver
14	chr11:66862600-66863000	Enhancers	iPS-15b Cell Line	embryonic stem cell
15	chr11:66862600-66863000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr11:66862600-66863000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr11:66862600-66863000	Enhancers	Duodenum Mucosa	Duodenum
18	chr11:66862600-66863200	Enhancers	Gastric	stomach
19	chr11:66862800-66863000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr11:66862800-66863000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
21	chr11:66862800-66863000	Flanking Bivalent TSS/Enh	HepG2	liver
22	chr11:66862800-66863200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
23	chr11:66863000-66863200	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr11:66863000-66866000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr11:66863000-66867400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr11:66863000-66870600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
27	chr11:66863000-66871200	Weak transcription	K562	blood
28	chr11:66863200-66867600	Weak transcription	Gastric	stomach
29	chr11:66865400-66866400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
30	chr11:66866000-66867000	Enhancers	Left Ventricle	heart
31	chr11:66866000-66867000	Enhancers	Right Atrium	heart
32	chr11:66866000-66867000	Enhancers	Right Ventricle	heart
33	chr11:66866000-66867200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr11:66866000-66867600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr11:66866000-66867800	Enhancers	Adipose Nuclei	Adipose
36	chr11:66866200-66866400	Enhancers	Spleen	Spleen
37	chr11:66866200-66867400	Enhancers	GM12878-XiMat	blood
38	chr11:66866200-66868200	Enhancers	Breast Myoepithelial Primary Cells	Breast
39	chr11:66866400-66866600	Enhancers	ES-I3 Cell Line	embryonic stem cell
40	chr11:66866400-66866600	Enhancers	H1 Cell Line	embryonic stem cell
41	chr11:66866400-66866600	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr11:66866400-66866800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr11:66866400-66867000	Enhancers	Fetal Muscle Leg	muscle
44	chr11:66866400-66867600	Weak transcription	Spleen	Spleen
45	chr11:66866400-66868200	Enhancers	Primary neutrophils fromperipheralblood	blood
46	chr11:66866400-66868200	Enhancers	Fetal Thymus	thymus
47	chr11:66866400-66868400	Enhancers	Primary hematopoietic stem cells short term culture	blood
48	chr11:66866600-66868200	Enhancers	Primary B cells from peripheral blood	blood
49	chr11:66866600-66871400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
50	chr11:66866800-66867000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links